OpenLoop acquires AI communication platform Hey Revia as digital health M&A heats up

OpenLoop has acquired Hey Revia, an AI-powered communication platform, in a move that extends the virtual care company's technology stack and reflects the accelerating pace of consolidation across digital health. The deal, reported by MobiHealthNews, adds intelligent patient communication capabilities to OpenLoop's existing infrastructure at a time when telehealth operators are racing to differentiate through AI.

Consolidation picks up in virtual care

OpenLoop has built its business around enabling healthcare organizations to deploy virtual care services, and Hey Revia's AI communication tools fit squarely into that strategy. Rather than building such capabilities from scratch, the acquisition gives OpenLoop a ready-made system designed to handle the kind of ongoing, automated patient engagement that virtual care models depend on. The terms of the transaction were not disclosed.

The deal arrives as acquirers across the health technology sector look to plug AI functionality into existing workflows quickly. Hey Revia had positioned its platform around improving how clinical teams communicate with patients at scale, a problem that grows more complex as telehealth volumes climb.

FDA breakthrough status for a neurology device

On the regulatory front, the FDA granted breakthrough device designation to Aurenar for a device targeting brain bleeds, according to MobiHealthNews. Breakthrough designation is reserved for devices that offer the potential for more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions, and it triggers a more collaborative, expedited review process with the agency.

Intracranial hemorrhage remains one of the most time-critical conditions in emergency medicine, where speed of detection directly affects patient outcomes. Aurenar's designation signals that the FDA sees the device as meaningfully advancing what clinicians currently have available, and it puts the company on a faster path toward potential clearance.

Sharecare builds AI navigation on AWS infrastructure

Sharecare announced it is using Amazon Web Services to power AskMD, its AI health navigation tool. The integration relies on Amazon Bedrock, AWS's managed service for building applications on top of foundation models, to orchestrate multiple AI models simultaneously. As MobiHealthNews reported, the platform is designed to help users work through symptoms, understand insurance benefits, find providers, and assess care options, all within a single interface.

Using Bedrock to coordinate several foundation models rather than relying on a single one gives Sharecare the flexibility to route different types of queries to the models best suited to answer them. It also positions the company within the growing ecosystem of health technology firms building on major cloud AI infrastructure rather than training proprietary models.

Housing stability draws healthcare investment

Upside, a platform focused on housing stability for healthcare populations, raised $20 million, per MobiHealthNews. The round draws attention to the social determinants of health space, where investors are increasingly funding companies that address non-clinical factors, such as stable housing, that have measurable effects on health outcomes and total cost of care.

AI workforce and data standards take center stage

Beyond deals and devices, two broader conversations shaped the week's coverage. HIMSS convened its AI in Healthcare Forum in Boston, where health system leaders gathered to discuss practical deployment of AI, risk management, and building trust among both patients and clinicians. Separately, Álvaro Alonso Zorita of Spain's National Health System told HIMSS TV that common data standards are essential for the secondary use of health data and for scaling AI tools efficiently across Spain's healthcare system.

The emphasis on data standardization is not unique to Spain. Health IT leaders across multiple markets have identified fragmented data infrastructure as the primary bottleneck slowing AI adoption, even when the models themselves are ready to deploy.

What's next

Aurenar's next milestone will be engaging with the FDA's expedited review process now that breakthrough status is confirmed. For OpenLoop, integrating Hey Revia's communication technology into its platform will be the near-term operational focus. And Sharecare's AskMD rollout on Amazon Bedrock gives the market a live test case for how multi-model AI orchestration performs at scale in a consumer health navigation context.